新型单等位ALG5变异导致迟发性ADPKD及小管间质纤维化
该研究在2个爱尔兰家系中鉴定出单等位ALG5变异p.R79W,共分离于23人(18人临床受累),表现为迟发性ADPKD样表型伴小管间质损伤。机制上ALG5功能异常导致uromodulin成熟和转运障碍,并引起CKD相关蛋白失调。
要点
- ALG5单等位变异p.R79W可导致迟发性ADPKD样表型伴小管间质纤维化。
- 患者肾组织中ALG5高尔基体定位异常,uromodulin在内质网异常积聚。
- 临床受累个体血浆和尿uromodulin水平降低。
核心结论
- ALG5功能异常影响N-糖基化及GPI锚定蛋白uromodulin的成熟与转运,导致肾脏结构和功能改变。
- ALG5是迟发性ADPKD的致病基因,本研究为ADPKD-ALG5的分子机制提供了新见解。
研究设计与样本
- 研究纳入2个遗传相关爱尔兰家系,采用全外显子组和靶向测序进行共分离分析。
- 对肾活检组织进行免疫组化检查,并进行靶向(UMOD、MUC1)和非靶向血浆蛋白质组及N-糖组研究。
主要发现
- 鉴定出单等位ALG5变异[GRCh37 (NM_013338.5): g.37569565G>A, c.235C>T; p.R79W],在23人中共分离,其中18人临床受累。
- 患者肾小管细胞中ALG5高尔基体定位异常。
- 患者肾组织中uromodulin在内质网异常积聚,而mucin-1无此现象。
- 临床受累个体血浆和尿uromodulin水平降低。
- 蛋白质组和糖蛋白质组分析显示CKD相关蛋白失调。
临床怎么用
- 对表现迟发性ADPKD伴小管间质损伤的患者,可考虑ALG5基因检测。
- 检测血浆和尿uromodulin水平可能有助于识别ALG5相关肾病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Monoallelic variants in the ALG5 gene encoding asparagine-linked glycosylation protein 5 homolog (ALG5) have been recently shown to disrupt polycystin-1 (PC1) maturation and trafficking via underglycosylation, causing an autosomal dominant polycystic kidney disease-like (ADPKD-like) phenotype and interstitial fibrosis. In this report, we present clinical, genetic, histopathologic, and protein structure and functional correlates of a new ALG5 variant, p.R79W, that we identified in 2 distant genetically related Irish families displaying an atypical late-onset ADPKD phenotype combined with tubulointerstitial damage. METHODS: Whole exome and targeted sequencing were used for segregation analysis of available relatives. This was followed by immunohistochemistry examinations of kidney biopsies, and targeted (UMOD, MUC1) and untargeted plasma proteome and N-glycomic studies. RESULTS: We identified a monoallelic ALG5 variant [GRCh37 (NM_013338.5): g.37569565G>A, c.235C>T; p.R79W] that cosegregates in 23 individuals, of whom 18 were clinically affected. We detected abnormal localization of ALG5 in the Golgi apparatus of renal tubular cells in patients' kidney specimens. Further, we detected the pathological accumulation of uromodulin, an N-glycosylated glycosylphosphatidylinositol (GPI)-anchored protein, in the endoplasmic reticulum (ER), but not mucin-1, an O- and N-glycosylated protein. Biochemical investigation revealed decreased plasma and urinary uromodulin levels in clinically affected individuals. Proteomic and glycoproteomic profiling revealed the dysregulation of chronic kidney disease (CKD)-associated proteins. CONCLUSION: ALG5 dysfunction adversely affects maturation and trafficking of N-glycosylated and GPI anchored protein uromodulin, leading to structural and functional changes in the kidney. Our findings confirm ALG5 as a cause of late-onset ADPKD and provide additional insight into the molecular mechanisms of ADPKD-ALG5.
引用
- Elhassan EAE, Kmochová T, Benson KA, et al. A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis. Kidney Int Rep. 2024. PMID: 39081747. doi:10.1016/j.ekir.2024.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。